Biomarkers to Predict and Monitor Response to Infliximab
Clinical trial NCT04655729 · UNKNOWN
Trial details
- NCT number
- NCT04655729
- Sponsor
- Massachusetts General Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-18
- Primary completion
- 2022-11-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.